Ambalal Sarabhai Enterprises has informed that the Company provided remote e-voting and voting through ballot forms facilities to the Members of the Company for 41st Annual General Meeting. Based on the Scrutinisers Consolidated Report, both Resolutions contained in the 41st Annual General Meeting Notice have been duly passed on the date of 41st AGM i.e. 29th August, 2019 and the same has been attached as Annexure - I along with Declaration of results.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1853.20 |
| Dr. Reddys Lab | 1320.00 |
| Cipla | 1368.45 |
| Zydus Lifesciences | 938.80 |
| Lupin | 2444.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: